This Monday, a research and innovation project was launched that seeks to develop the next generation of safe, sustainable, and high-value biomolecules. It is the result of a partnership between the Faculty of Biotechnology of the Portuguese Catholic University and the international company Biorbis, which chose Porto to carry out its research and innovation investment in Europe.
This program foresees an initial private investment of three million, with a potential of 23 million over the next five years, in the research and innovation project that seeks to develop the next generation of safe, sustainable, and high-value biomolecules.
"This collaboration, with a five-year horizon, will begin with the integration of 40 researchers to develop a private research project – Circulas – which will be integrated into the facilities of the Centre for Biotechnology and Fine Chemistry of the Faculty of Biotechnology", said Manuela Pintado, director of said associated laboratory.
"Biorbis will commercialize new sustainable molecules, from Portugal, resulting from this partnership, where 40 researchers will actively seek new sources and processes to develop sustainable and high-value molecules", says Jorge Leal, co-founder and co-director of Biorbis.
"Through this partnership, which is based on the principles of the circular economy, and which is aligned with the Green Deal, we intend to transform Portugal into a 'hub' for the development of new biomolecules, to be marketed with applications in plant, animal, and human nutrition", adds John Melo, also co-founder and co-director of Biorbis.